瘤微环境对T细胞功能和生存的调节
Nikita Mani1, Dathan Andrews2, Rebecca C Obeng2,3,4
1Department of Pathology, Northwestern University Feinberg School of Medicine, Chicago, IL, United States.
Frontiers in cell and developmental biology
|June 5, 2023
概括
癌症免疫疗法依赖于T细胞,但瘤微环境 (TME) 存在挑战. 了解TME因素是改善T细胞功能以获得更好的癌症治疗反应的关键.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 癌症生物学 癌症生物学
背景情况:
- 癌症免疫疗法代表了癌症治疗的重大进步.
- 对于有效的抗瘤免疫力和持续的临床反应,T细胞至关重要.
- 瘤微环境 (TME) 包含各种细胞,影响T细胞活性.
研究的目的:
- 讨论TME中调节T细胞功能和生存的因素.
- 突出TME复杂性对抗瘤免疫反应的影响.
- 确定影响T细胞在癌症中的疗效的关键相互作用.
主要方法:
- 对T细胞相互作用在TME中的现有文献的审查.
- 分析影响T细胞功能的因素,包括细胞成分,瘤生物学和新陈代谢.
- 讨论瘤特征与T细胞反应之间的相互作用.
主要成果:
- TME包含一个复杂的细胞环境,影响T细胞的功能和生存.
- 瘤生物学,结构特征,营养的可用性和新陈代谢显著影响T细胞质量.
- 在TME内部的相互作用是整体抗瘤免疫反应的关键决定因素.
结论:
- 由于TME的复杂性,实现强大而持久的T细胞反应具有挑战性.
- 在TME中调节T细胞功能对于提高免疫疗法的疗效至关重要.
- 对TME-T细胞动态的进一步研究可以优化癌症治疗策略.
相关概念视频
The Tumor Microenvironment
6.7K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.7K
Tumor Immunotherapy
575
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
575
T Cell Activation and Clonal Selection
838
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
838
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Cell-mediated Immune Responses
69.2K
Overview
69.2K
T Cell Types and Functions
1.1K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.1K


